Clinical trial
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in…
NCT00078559 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00078559 |
|---|---|
| Title | Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults |
| Official title | The Use of Campath-1H, Tacrolimus, and Sirolimus Followed by Sirolimus Withdrawal in Renal Transplant Patients |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | Immune Tolerance Network (ITN) |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Transplantation, Kidney Disease |
| Intervention type | Drug, Procedure |
| Interventions | Alemtuzumab, Sirolimus, Tacrolimus, Kidney transplant, Methylprednisolone (or equivalent), Acetaminophen, Diphenhydramine, Trimethoprim (TMP)/Sulfa (Bactrim, Septra), Valgancyclovir and 4 more |
| Enrollment | 10 |
| Start date | Nov 1, 2003 |
| Primary completion | Feb 1, 2010 |
| Completion | Feb 1, 2010 |
| First posted | Mar 2, 2004 |
| Last update posted | Jun 29, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: